NCT00197795View on ClinicalTrials.gov

Immunogenicity and Reactogenicity of a Meningococcal B Outer Membrane Vesicle Vaccine Given in a 0,6,12 Month Schedule to Health UK Adults

PHASE2CompletedINTERVENTIONAL
Enrollment

30

Participants

Timeline

Start Date

January 31, 2005

Primary Completion Date

December 31, 2006

Study Completion Date

December 31, 2006

Conditions
Neisseria Meningitidis
Interventions
BIOLOGICAL

"Meningococcal outer membrane vesicle vaccine MenBVac"

All Listed Sponsors
lead

Public Health England

OTHER_GOV

NCT00197795 - Immunogenicity and Reactogenicity of a Meningococcal B Outer Membrane Vesicle Vaccine Given in a 0,6,12 Month Schedule to Health UK Adults | Biotech Hunter | Biotech Hunter